Lyophilisation

Lyophilisation, also known as freeze-drying, is a preservation and stabilisation process that removes water from frozen materials by sublimation and desorption, producing a dry, porous product with preserved structure and activity. The process typically involves three stages: freezing, primary drying where ice sublimes under reduced pressure, and secondary drying where residual bound moisture is removed. Lyophilised products are highly stable, reconstitute efficiently, and are suitable for long-term storage.

The biopharmaceutical industry uses lyophilisation extensively for vaccines, monoclonal antibodies, peptides, enzymes, and injectable formulations that are unstable in liquid form. Cycle development requires careful optimisation of temperature and pressure profiles to prevent product collapse, ensure consistent cake structure, and maintain potency. Formulation design includes cryoprotectants and lyoprotectants such as sugars that stabilise proteins during freezing and drying. Regulatory expectations require validated lyophilisation processes, robust in-process controls, and stability data demonstrating shelf-life and reconstitution performance. As biologic complexity grows and global distribution needs increase, lyophilisation remains a critical technology enabling stable, transportable, and clinically reliable therapeutic products.